SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-172196
Filing Date
2015-05-05
Accepted
2015-05-05 16:31:53
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d909298d10q.htm 10-Q 272719
2 EX-31.1 d909298dex311.htm EX-31.1 8583
3 EX-31.2 d909298dex312.htm EX-31.2 8580
4 EX-32.1 d909298dex321.htm EX-32.1 5072
  Complete submission text file 0001193125-15-172196.txt   3184888

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glyc-20150331.xml EX-101.INS 360654
6 XBRL TAXONOMY EXTENSION SCHEMA glyc-20150331.xsd EX-101.SCH 35435
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glyc-20150331_cal.xml EX-101.CAL 37110
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glyc-20150331_def.xml EX-101.DEF 124581
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20150331_lab.xml EX-101.LAB 290723
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20150331_pre.xml EX-101.PRE 196267
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 15833452
SIC: 2834 Pharmaceutical Preparations